185 related articles for article (PubMed ID: 22105149)
1. Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.
Lee E; Ingles SA; Van Den Berg D; Wang W; Lavallee C; Huang MH; Crandall CJ; Stanczyk FZ; Greendale GA; Ursin G
Menopause; 2012 Mar; 19(3):302-10. PubMed ID: 22105149
[TBL] [Abstract][Full Text] [Related]
2. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
[TBL] [Abstract][Full Text] [Related]
3. Increases in serum estrone sulfate level are associated with increased mammographic density during menopausal hormone therapy.
Crandall CJ; Guan M; Laughlin GA; Ursin GA; Stanczyk FZ; Ingles SA; Barrett-Connor E; Greendale GA
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1674-81. PubMed ID: 18628419
[TBL] [Abstract][Full Text] [Related]
4. Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study.
Lee E; Luo J; Su YC; Lewinger JP; Schumacher FR; Van Den Berg D; Wu AH; Bernstein L; Ursin G
Breast Cancer Res; 2014 Dec; 16(6):477. PubMed ID: 25499601
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
[TBL] [Abstract][Full Text] [Related]
6. Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density.
van Duijnhoven FJ; Peeters PH; Warren RM; Bingham SA; Uitterlinden AG; van Noord PA; Monninkhof EM; Grobbee DE; van Gils CH
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):462-7. PubMed ID: 16537702
[TBL] [Abstract][Full Text] [Related]
7. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.
Greendale GA; Reboussin BA; Sie A; Singh HR; Olson LK; Gatewood O; Bassett LW; Wasilauskas C; Bush T; Barrett-Connor E
Ann Intern Med; 1999 Feb; 130(4 Pt 1):262-9. PubMed ID: 10068383
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
9. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
[TBL] [Abstract][Full Text] [Related]
10. Hormone therapy use and mammographic density in postmenopausal Norwegian women.
Couto E; Qureshi SA; Hofvind S; Hilsen M; Aase H; Skaane P; Vatten L; Ursin G
Breast Cancer Res Treat; 2012 Feb; 132(1):297-305. PubMed ID: 22052325
[TBL] [Abstract][Full Text] [Related]
11. Effect of estrogen-progestin and estrogen on mammographic density.
Kaewrudee S; Anuwutnavin S; Kanpittaya J; Soontrapa S; Sakondhavat C
J Reprod Med; 2007 Jun; 52(6):513-20. PubMed ID: 17694969
[TBL] [Abstract][Full Text] [Related]
12. Growth factor genes and change in mammographic density after stopping combined hormone therapy in the California Teachers Study.
Lee E; Luo J; Schumacher FR; Van Den Berg D; Wu AH; Stram DO; Bernstein L; Ursin G
BMC Cancer; 2018 Nov; 18(1):1072. PubMed ID: 30400783
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone therapy and change in mammographic density.
Greendale GA; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Ursin G
J Natl Cancer Inst; 2003 Jan; 95(1):30-7. PubMed ID: 12509398
[TBL] [Abstract][Full Text] [Related]
14. The effect of transdermal testosterone on mammographic density in postmenopausal women not receiving systemic estrogen therapy.
Davis SR; Hirschberg AL; Wagner LK; Lodhi I; von Schoultz B
J Clin Endocrinol Metab; 2009 Dec; 94(12):4907-13. PubMed ID: 19850682
[TBL] [Abstract][Full Text] [Related]
15. Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal women.
Unfer TC; Figueiredo CG; Zanchi MM; Maurer LH; Kemerich DM; Duarte MM; Konopka CK; Emanuelli T
Climacteric; 2015 Jun; 18(3):379-88. PubMed ID: 25236970
[TBL] [Abstract][Full Text] [Related]
16. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
17. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.
Greendale GA; Palla SL; Ursin G; Laughlin GA; Crandall C; Pike MC; Reboussin BA
Am J Epidemiol; 2005 Nov; 162(9):826-34. PubMed ID: 16177147
[TBL] [Abstract][Full Text] [Related]
18. Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2003; 10(2):113-32. PubMed ID: 12627037
[TBL] [Abstract][Full Text] [Related]
19. Serum prolactin levels are positively associated with mammographic density in postmenopausal women.
Greendale GA; Huang MH; Ursin G; Ingles S; Stanczyk F; Crandall C; Laughlin GA; Barrett-Connor E; Karlamangla A
Breast Cancer Res Treat; 2007 Nov; 105(3):337-46. PubMed ID: 17260098
[TBL] [Abstract][Full Text] [Related]
20. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
